Ipsen Continues the Acquisition Process of Tercica, Inc. so as to Establish Its Global Presence in Endocrinology

PARIS--(BUSINESS WIRE)--Regulatory News: Ipsen (Paris:IPN) announced today that on 22 July 2008 it subscribed for additional shares of common stock of Tercica Inc. (NASDAQ:TRCA) and exercised in full the warrant issued by Tercica in October 2006, and converted in full the convertible notes, issued by Tercica in October 2006 and September 2007.